Read + Share
Taxonera C. Editorial: golimumab thresholds to achieve stringent medium- and long-term
therapeutic outcomes in patients with ulcerative colitis-Author's reply. Aliment Pharmacol Ther 2022;56:737-738.
PMID: 35879906
|
 |
|
Taxonera C. Editorial: golimumab thresholds to achieve stringent medium- and long-term
therapeutic outcomes in patients with ulcerative colitis-Author's reply. Aliment Pharmacol Ther 2022;56:737-738.
PMID: 35879906
|
|
|
|